Claudia Klein
CEO/ R & D / Diagnostician
- YENO Evolution GmbH Austria
Professional Information
Claudia
Klein
CEO/ R & D / Diagnostician
YENO Evolution GmbH Austria
Education, Honors & Awards
Array
M.Sc. D.I.
(1994)
Personal Information
France
Marseille
International Society of Complementary Medicine Research
Travel
More than 25 years
Claudia Klein is the CEO of YENO Evolution in Vienna/ Austria. Her company is leader in the filed of rejuvenation medicine (www.genos-fibrocell.com) and side effect free epigenetic cancer treatments.
She also has 20 years of experience as a cause diagnostician focusing on toxicology, cell dysfunction and epigenetics as well as holistic medicine (www.genos-health-institute.com/about-us). Her expertise is in biological regeneration and epigenetic medicine. She has been a speaker and lecturer in cause diagnostics and new approaches in medicine.
Over the past 15 years, Claudia has been researching the cell mechanisms of information-based epigenetics and the possibility of transmitting targeted information to cells and their biochemical functional processes. Her work includes the physiological, biochemical and above all cell-communicative regeneration pathways of the body. Her company focuses on research and development of groundbreaking applied epigenetics and personalized medicine topics. Her groundbreaking Research results in the field of cancer therapy were published worldwide in March 2022 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906504/)
Since then, she was invited to severals international conferences as speaker to present her work to a vast audience.https://www.oncology.scientexconference.com/speakers/Claudia-B-Klein Since March 2022 the GENOS REVERSE infusions have been available as (side effect free) magistral recipes/ drugs for patients with cancer.
Claudia also was able to develop the innovative product FIBROCELL that now is the market leader in cell rejuvenation - which is a breakthrough in the anti-aging industry. The products FIBROCELL (infusions) enable cell rejuvenation of up to 5 years within 3-4 weeks.
What others say about YENO:
"YENO is years ahead compared to the worldwide research and has developed its own Personalized Medicine Brand: GENOS with its own production line in Germany. YENO stands for a new, easy to use and modern medicine that combines the old knowledge from holistic and complementary medicine with state-of-the-art research."
The focus of Claudia’s work is based on consciousness in business and on the relationship to nature, humankind and the environment. She is looking forward to networking and connecting with other like-minded women and to share her business attitude based on conscious company leadership with others.
EntrepreneurDiagnosticianHumanitarian
